Germo Gericke

2.7k total citations · 1 hit paper
6 papers, 1.6k citations indexed

About

Germo Gericke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Germo Gericke has authored 6 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Neurology. Recurrent topics in Germo Gericke's work include Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Germo Gericke is often cited by papers focused on Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Germo Gericke collaborates with scholars based in United States, United Kingdom and Switzerland. Germo Gericke's co-authors include Scott T. Tagawa, Bernd J. Krause, Johann S. de Bono, Ken Herrmann, Michael J. Morris, Chandler H. Park, Michelle DeSilvio, Karim Fizazi, Euloge Kpamegan and Ghassan El‐Haddad and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Germo Gericke

5 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

2021 1.5k citations Oliver Sartor, Johann S. de Bono et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Germo Gericke United States	4	1.2k	1.0k	563	190	174	6	1.6k
Euloge Kpamegan United States	8	1.4k 1.2×	1.1k 1.0×	601 1.1×	234 1.2×	281 1.6×	11	1.8k
Chandler H. Park United States	8	1.2k 1.0×	1.1k 1.0×	602 1.1×	198 1.0×	186 1.1×	20	1.7k
Sue Ping Thang Singapore	9	1.3k 1.1×	1.2k 1.2×	566 1.0×	172 0.9×	93 0.5×	28	1.7k
Elisabeth Eppard Germany	22	1.3k 1.1×	1.6k 1.6×	708 1.3×	137 0.7×	167 1.0×	48	2.0k
Calogero D’Alessandria Germany	24	1.1k 0.9×	1.4k 1.4×	749 1.3×	123 0.6×	252 1.4×	77	2.1k
Aravind Ravi Kumar Australia	11	1.2k 1.1×	1.2k 1.1×	467 0.8×	166 0.9×	110 0.6×	24	1.6k
Anna Yordanova Germany	19	1.1k 1.0×	1.2k 1.2×	676 1.2×	122 0.6×	130 0.7×	39	1.6k
Ingo Klette Germany	12	842 0.7×	1.1k 1.0×	458 0.8×	71 0.4×	129 0.7×	21	1.3k
Christiane Schuchardt Germany	18	877 0.8×	1.3k 1.3×	867 1.5×	128 0.7×	185 1.1×	42	1.8k
Hans-Jürgen Wester Germany	18	1.1k 0.9×	1.3k 1.2×	520 0.9×	421 2.2×	229 1.3×	23	2.1k

Countries citing papers authored by Germo Gericke

Since Specialization

Citations

This map shows the geographic impact of Germo Gericke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Germo Gericke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Germo Gericke more than expected).

Fields of papers citing papers by Germo Gericke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Germo Gericke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Germo Gericke. The network helps show where Germo Gericke may publish in the future.

Co-authorship network of co-authors of Germo Gericke

This figure shows the co-authorship network connecting the top 25 collaborators of Germo Gericke. A scholar is included among the top collaborators of Germo Gericke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Germo Gericke. Germo Gericke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Bodei, Lisa, Marta Cremonesi, Mahila Ferrari, et al.. (2025). Dosimetry of [¹⁷⁷Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial. Journal of Nuclear Medicine. 66(3). 449–456. 6 indexed citations

2.

Desai, Prachi, et al.. (2025). Abstract 575: 225Ac-SSO110 as next-generation SSTR2 targeting radiopharmaceutical for small cell lung cancer. Cancer Research. 85(8_Supplement_1). 575–575.

3.

Strosberg, Jonathan, Martyn Caplin, Pamela L. Kunz, et al.. (2021). Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors.. Journal of Clinical Oncology. 39(15_suppl). 4112–4112. 46 indexed citations

4.

Morris, Michael J., Johann S. de Bono, Kim N., et al.. (2021). Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION).. Journal of Clinical Oncology. 39(18_suppl). LBA4–LBA4. 54 indexed citations

5.

Sartor, Oliver, Johann S. de Bono, Kim N., et al.. (2021). Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. New England Journal of Medicine. 385(12). 1091–1103. 1487 indexed citations breakdown →

6.

Gericke, Germo, et al.. (1998). Fluorescence-imaging assay for cytotoxic plaque formation and for growth toward confluency of adherent cells. Cytometry. 33(1). 41–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact